Anavex Life Sciences Corp (AVXL)

[Biostockclub]

New SA article. Moderators, please note: the article mentions the name of one BP and not AVXL, HOWEVER, the broad TOPIC is granting approval for new drugs under the 21st Cen Cures Act and the new FDA. This is a topic which MANY in this board have discussed as being very relevant to AVXL as a possible/probable path forward toward FDA approval of our A2-73 compound in clinical trials (AD, and more to come, soon.) Appreciate your consideration. Thank you.


Fellow investors,
This looks to be BP's immediate reaction to a new FDA/Cures Act environment: defend the old way of approval as THE ONLY WAY, for obvious reasons. Would not be surprised to see more of this type of argument justifying "the old way" to keep new drugs from encroaching on their monopoly. (My opinion. A PR war waged to frighten people into thinking drugs need the big, long, standard trial process - which hasn't worked - but which keeps the monopoly going.)
Interesting to note LLY's failed AD drug cost $10B...that is unreal!



There Are Failures, You Know $LLY
http://www.seekingalpha.com/article/4071831

Bio